Flint, T. R., Jones, J. O., Ferrer, M., Colucci, F., Janowitz, T. (March 2018) A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy. Semin Oncol. ISSN 0093-7754
Abstract
Despite their abilities to elicit immune responses, both syngeneic tumors and the half-mismatched placenta grow in the host, unlike a tissue allograft that is aggressively rejected. This is because of local and systemic factors that contribute to the immunologic privilege of tumors and the placenta. Checkpoint blockade immunotherapies subvert this privilege, with spectacularly beneficial outcomes in subsets of patients with certain types of cancer. A challenge for the community of scientists and clinicians is to replicate these successes in pregnant patients with cancer, without harm to the placenta. Here we compare and contrast the immunology of cancers and the placenta, and suggest that immunotherapy for pregnant patients with cancer may be a reasonable option, but that this should be explored systematically.
| Item Type: | Paper |
|---|---|
| Subjects: | diseases & disorders > cancer diseases & disorders > cancer > drugs and therapies > Immunotherapy |
| CSHL Authors: | |
| Communities: | CSHL labs > Janowitz lab |
| Highlight: | Janowitz, Tobias |
| Depositing User: | Matthew Dunn |
| Date: | 26 March 2018 |
| Date Deposited: | 10 Oct 2018 15:12 |
| Last Modified: | 10 Oct 2018 15:12 |
| Related URLs: | |
| URI: | https://repository.cshl.edu/id/eprint/37242 |
Actions (login required)
 |
Administrator's edit/view item |
